628 related articles for article (PubMed ID: 18321696)
21. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients.
Nguyen GC; Kaplan GG; Harris ML; Brant SR
Am J Gastroenterol; 2008 Jun; 103(6):1443-50. PubMed ID: 18513271
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).
Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA
Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654
[TBL] [Abstract][Full Text] [Related]
23. Impact of Clostridium difficile on inflammatory bowel disease.
Issa M; Vijayapal A; Graham MB; Beaulieu DB; Otterson MF; Lundeen S; Skaros S; Weber LR; Komorowski RA; Knox JF; Emmons J; Bajaj JS; Binion DG
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234
[TBL] [Abstract][Full Text] [Related]
24. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
[TBL] [Abstract][Full Text] [Related]
25. Impact of autonomic dysfunction on inflammatory bowel disease.
Ananthakrishnan AN; Issa M; Barboi A; Jaradeh S; Zadvornova Y; Skaros S; Johnson K; Otterson MF; Binion DG
J Clin Gastroenterol; 2010 Apr; 44(4):272-9. PubMed ID: 19727003
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease.
Bardella MT; Elli L; De Matteis S; Floriani I; Torri V; Piodi L
Ann Med; 2009; 41(2):139-43. PubMed ID: 18777226
[TBL] [Abstract][Full Text] [Related]
27. Increased prevalence of lactose malabsorption in Crohn's disease patients at low risk for lactose malabsorption based on ethnic origin.
Mishkin B; Yalovsky M; Mishkin S
Am J Gastroenterol; 1997 Jul; 92(7):1148-53. PubMed ID: 9219788
[TBL] [Abstract][Full Text] [Related]
28. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
Ben Hamida KS; Serghini M; Ksontini I; Kedadi H; Ben Yaghléne L; Bougassas W; Dougui MH
Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
[TBL] [Abstract][Full Text] [Related]
29. The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease.
Cucino C; Sonnenberg A
Am J Gastroenterol; 2001 Jul; 96(7):2107-12. PubMed ID: 11467640
[TBL] [Abstract][Full Text] [Related]
30. Relationship of inflammatory bowel disease and primary sclerosing cholangitis.
Fausa O; Schrumpf E; Elgjo K
Semin Liver Dis; 1991 Feb; 11(1):31-9. PubMed ID: 2047887
[TBL] [Abstract][Full Text] [Related]
31. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life.
Palm Ø; Bernklev T; Moum B; Gran JT
J Rheumatol; 2005 Sep; 32(9):1755-9. PubMed ID: 16142874
[TBL] [Abstract][Full Text] [Related]
32. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients.
Nguyen GC; Sam J
Am J Gastroenterol; 2008 Sep; 103(9):2272-80. PubMed ID: 18684186
[TBL] [Abstract][Full Text] [Related]
33. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.
Clayton EM; Rea MC; Shanahan F; Quigley EM; Kiely B; Hill C; Ross RP
Am J Gastroenterol; 2009 May; 104(5):1162-9. PubMed ID: 19319128
[TBL] [Abstract][Full Text] [Related]
34. [Pulmonary functional disorders in ulcerative colitis and Crohn's disease].
Sommer H; Schmidt M; Gruber KD
Dtsch Med Wochenschr; 1986 May; 111(21):812-5. PubMed ID: 3698863
[TBL] [Abstract][Full Text] [Related]
35. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of inflammatory bowel disease among children in Poland. A prospective, population-based, 2-year study, 2002-2004.
Karolewska-Bochenek K; Lazowska-Przeorek I; Albrecht P; Grzybowska K; Ryzko J; Szamotulska K; Radzikowski A; Landowski P; Krzesiek E; Ignys I; Fyderek K; Czerwionka-Szaflarska M; Jarocka-Cyrta E
Digestion; 2009; 79(2):121-9. PubMed ID: 19321943
[TBL] [Abstract][Full Text] [Related]
37. Defense mechanisms in inflammatory bowel disease.
Hyphantis TN; Triantafillidis JK; Pappa S; Mantas C; Kaltsouda A; Cherakakis P; Alamanos Y; Manousos ON; Mavreas VG
J Gastroenterol; 2005 Jan; 40(1):24-30. PubMed ID: 15692786
[TBL] [Abstract][Full Text] [Related]
38. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003.
Hutfless SM; Weng X; Liu L; Allison J; Herrinton LJ
Gastroenterology; 2007 Dec; 133(6):1779-86. PubMed ID: 18054550
[TBL] [Abstract][Full Text] [Related]
39. An initial report of sleep disturbance in inactive inflammatory bowel disease.
Keefer L; Stepanski EJ; Ranjbaran Z; Benson LM; Keshavarzian A
J Clin Sleep Med; 2006 Oct; 2(4):409-16. PubMed ID: 17557469
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease.
Sonoda K; Ikeda S; Mizuta Y; Miyahara Y; Kohno S
J Gastroenterol; 2004 Oct; 39(10):948-54. PubMed ID: 15549447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
